skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state

Authors:
; ; ; ; ; ORCiD logo; ; ; ; ; ; ; ;
Publication Date:
Research Org.:
Argonne National Lab. (ANL), Argonne, IL (United States). Advanced Photon Source (APS)
Sponsoring Org.:
NIHFOREIGN
OSTI Identifier:
1347753
Resource Type:
Journal Article
Journal Name:
Nature Communications
Additional Journal Information:
Journal Volume: 8; Journal Issue: 02, 2017; Journal ID: ISSN 2041-1723
Publisher:
Nature Publishing Group
Country of Publication:
United States
Language:
ENGLISH

Citation Formats

Rossey, Iebe, Gilman, Morgan S. A., Kabeche, Stephanie C., Sedeyn, Koen, Wrapp, Daniel, Kanekiyo, Masaru, Chen, Man, Mas, Vicente, Spitaels, Jan, Melero, José A., Graham, Barney S., Schepens, Bert, McLellan, Jason S., and Saelens, Xavier. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. United States: N. p., 2017. Web. doi:10.1038/ncomms14158.
Rossey, Iebe, Gilman, Morgan S. A., Kabeche, Stephanie C., Sedeyn, Koen, Wrapp, Daniel, Kanekiyo, Masaru, Chen, Man, Mas, Vicente, Spitaels, Jan, Melero, José A., Graham, Barney S., Schepens, Bert, McLellan, Jason S., & Saelens, Xavier. Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state. United States. doi:10.1038/ncomms14158.
Rossey, Iebe, Gilman, Morgan S. A., Kabeche, Stephanie C., Sedeyn, Koen, Wrapp, Daniel, Kanekiyo, Masaru, Chen, Man, Mas, Vicente, Spitaels, Jan, Melero, José A., Graham, Barney S., Schepens, Bert, McLellan, Jason S., and Saelens, Xavier. Mon . "Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state". United States. doi:10.1038/ncomms14158.
@article{osti_1347753,
title = {Potent single-domain antibodies that arrest respiratory syncytial virus fusion protein in its prefusion state},
author = {Rossey, Iebe and Gilman, Morgan S. A. and Kabeche, Stephanie C. and Sedeyn, Koen and Wrapp, Daniel and Kanekiyo, Masaru and Chen, Man and Mas, Vicente and Spitaels, Jan and Melero, José A. and Graham, Barney S. and Schepens, Bert and McLellan, Jason S. and Saelens, Xavier},
abstractNote = {},
doi = {10.1038/ncomms14158},
journal = {Nature Communications},
issn = {2041-1723},
number = 02, 2017,
volume = 8,
place = {United States},
year = {2017},
month = {2}
}

Works referenced in this record:

Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion
journal, August 2001

  • Gonzalez-Reyes, L.; Ruiz-Arguello, M. B.; Garcia-Barreno, B.
  • Proceedings of the National Academy of Sciences, Vol. 98, Issue 17
  • DOI: 10.1073/pnas.151098198

Generation of stable monoclonal antibody–producing B cell receptor–positive human memory B cells by genetic programming
journal, December 2009

  • Kwakkenbos, Mark J.; Diehl, Sean A.; Yasuda, Etsuko
  • Nature Medicine, Vol. 16, Issue 1
  • DOI: 10.1038/nm.2071

Contribution of the Respiratory Syncytial Virus G Glycoprotein and Its Secreted and Membrane-Bound Forms to Virus Replication in Vitro and in Vivo
journal, October 2001

  • Teng, Michael N.; Whitehead, Stephen S.; Collins, Peter L.
  • Virology, Vol. 289, Issue 2
  • DOI: 10.1006/viro.2001.1138

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis
journal, May 2015

  • Van Roy, Maarten; Ververken, Cedric; Beirnaert, Els
  • Arthritis Research & Therapy, Vol. 17, Issue 1
  • DOI: 10.1186/s13075-015-0651-0

iMOSFLM : a new graphical interface for diffraction-image processing with MOSFLM
journal, March 2011

  • Battye, T. Geoff G.; Kontogiannis, Luke; Johnson, Owen
  • Acta Crystallographica Section D Biological Crystallography, Vol. 67, Issue 4
  • DOI: 10.1107/S0907444910048675

Coot model-building tools for molecular graphics
journal, November 2004

  • Emsley, Paul; Cowtan, Kevin
  • Acta Crystallographica Section D Biological Crystallography, Vol. 60, Issue 12, p. 2126-2132
  • DOI: 10.1107/S0907444904019158

Identification of nucleolin as a cellular receptor for human respiratory syncytial virus
journal, August 2011

  • Tayyari, Farnoosh; Marchant, David; Moraes, Theo J.
  • Nature Medicine, Vol. 17, Issue 9
  • DOI: 10.1038/nm.2444

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus
journal, October 2013


Naturally occurring antibodies devoid of light chains
journal, June 1993

  • Hamers-Casterman, C.; Atarhouch, T.; Muyldermans, S.
  • Nature, Vol. 363, Issue 6428
  • DOI: 10.1038/363446a0

Development of a Humanized Monoclonal Antibody (MEDI‐493) with Potent In Vitro and In Vivo Activity against Respiratory Syncytial Virus
journal, November 1997

  • Johnson, Syd; Oliver, Cynthia; Prince, Gregory A.
  • The Journal of Infectious Diseases, Vol. 176, Issue 5
  • DOI: 10.1086/514115

PHENIX : building new software for automated crystallographic structure determination
journal, October 2002

  • Adams, Paul D.; Grosse-Kunstleve, Ralf W.; Hung, Li-Wei
  • Acta Crystallographica Section D Biological Crystallography, Vol. 58, Issue 11
  • DOI: 10.1107/S0907444902016657

How good are my data and what is the resolution?
journal, June 2013

  • Evans, Philip R.; Murshudov, Garib N.
  • Acta Crystallographica Section D Biological Crystallography, Vol. 69, Issue 7
  • DOI: 10.1107/S0907444913000061

Structure of Respiratory Syncytial Virus Fusion Glycoprotein in the Postfusion Conformation Reveals Preservation of Neutralizing Epitopes
journal, May 2011

  • McLellan, J. S.; Yang, Y.; Graham, B. S.
  • Journal of Virology, Vol. 85, Issue 15
  • DOI: 10.1128/JVI.00555-11

Molecular basis for the preferential cleft recognition by dromedary heavy-chain antibodies
journal, March 2006

  • De Genst, E.; Silence, K.; Decanniere, K.
  • Proceedings of the National Academy of Sciences, Vol. 103, Issue 12
  • DOI: 10.1073/pnas.0505379103

Molecular mechanism of respiratory syncytial virus fusion inhibitors
journal, December 2015

  • Battles, Michael B.; Langedijk, Johannes P.; Furmanova-Hollenstein, Polina
  • Nature Chemical Biology, Vol. 12, Issue 2
  • DOI: 10.1038/nchembio.1982

Characterization of a Prefusion-Specific Antibody That Recognizes a Quaternary, Cleavage-Dependent Epitope on the RSV Fusion Glycoprotein
journal, July 2015


Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
journal, August 2013

  • Corti, Davide; Bianchi, Siro; Vanzetta, Fabrizia
  • Nature, Vol. 501, Issue 7467
  • DOI: 10.1038/nature12442

Discovery of an Oral Respiratory Syncytial Virus (RSV) Fusion Inhibitor (GS-5806) and Clinical Proof of Concept in a Human RSV Challenge Study
journal, January 2015

  • Mackman, Richard L.; Sangi, Michael; Sperandio, David
  • Journal of Medicinal Chemistry, Vol. 58, Issue 4
  • DOI: 10.1021/jm5017768

Neutralizing antibodies against the preactive form of respiratory syncytial virus fusion protein offer unique possibilities for clinical intervention
journal, February 2012

  • Magro, M.; Mas, V.; Chappell, K.
  • Proceedings of the National Academy of Sciences, Vol. 109, Issue 8
  • DOI: 10.1073/pnas.1115941109

Respiratory Syncytial Virus Infection in Elderly and High-Risk Adults
journal, April 2005

  • Falsey, Ann R.; Hennessey, Patricia A.; Formica, Maria A.
  • New England Journal of Medicine, Vol. 352, Issue 17
  • DOI: 10.1056/NEJMoa043951

Prefusion F–specific antibodies determine the magnitude of RSV neutralizing activity in human sera
journal, October 2015


Phaser crystallographic software
journal, July 2007

  • McCoy, Airlie J.; Grosse-Kunstleve, Ralf W.; Adams, Paul D.
  • Journal of Applied Crystallography, Vol. 40, Issue 4
  • DOI: 10.1107/S0021889807021206